- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Alnylam Pharmaceuticals Inc
+ Add to WatchlistALNY:US
29.6900 USD 0.4200 1.39%As of 20:10:00 ET on 06/17/2013.
Snapshot for Alnylam Pharmaceuticals Inc (ALNY)
| Open: | 30.4100 | Day's Range: | 29.6200 - 30.4100 | Volume: | 375,767 |
|---|---|---|---|---|---|
| Previous Close: | 30.1100 | 52wk Range: | 11.2000 - 31.7900 | 1-Yr Rtn: | +152.68% |
Key Statistics for ALNY
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -1.1600 |
| Est. EPS (USD) (12/2013) | -1.2270 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 1,845.86 |
| Shares Outstanding (M) | 62.17 |
| 30 Day Average Volume | 474,521 |
| Price/Book (mrq) | 5.9210 |
| Price/Sale (ttm) | 24.5093 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/06/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ALNY
Company Profile & Key Executives for ALNY
Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.
| John M MaraganoreChief Executive Officer | Barry E GreenePresident/COO |
| Akshay K VaishnawExec VP/Chief Medical Officer | Laurence E ReidSenior VP/Chief Business Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ALNY News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page